About this trial
This study aims to evaluate the feasibility of Laser Speckle Contrast Imaging for perioperative perfusion assessment of the lower extremity before, during, and after revascularization.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Scheduled for lower-extremity revascularization
Undergoing pre- and postoperative indocyanine near-infrared fluorescence perfusion measurements
Disqualifiers
None
Trial population
The population of this study will undergo a revascularization of the lower extremity due to peripheral artery disease. Such revascularization can be thrombo-endarterectomy (TEA), or endovascular percutaneous transluminal angioplasty (PTA).
Trial design
Cohort
Prospective
Treatments tested in this trial
Laser Speckle Contrast Imaging
Diagnostic testMeasurement with LSCI device
Treatment groups
Trial outcomes
Primary outcomes
To assess the feasibility and the quantification of laser speckle contrast imaging for monitoring of perfusion of the lower extremities during and following revascularization
Feasibility
Secondary outcomes
Correlation of pre-, intra- and postsurgery laser speckle contrast imaging (LSCI) findings with the pre-, intra- and post-temperature of the patient's foot
Temperature
Comparative analysis of LSCI with standard of care near-infrared fluorescence imaging using ICG
ICG
Exploration of quantitative approaches to LSCI analysis, including assessment of blood flow pulsatility
Correlation of quantified LSCI recordings to clinical outcomes.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.